Zinc finger gene therapy in the brain for treating Huntington's disease

Project Information

Fingers4Cure

Grant agreement ID: 641232

DOI

10.3030/641232

Project closed

EC signature date 28 January 2015

Start date 1 February 2015

End date 31 July 2016

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

€ 149 995,00

EU contribution

€ 149 995,00

Coordinated by

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
United Kingdom

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (3)

A shared mechanism of muscle wasting in cancer and Huntington’s disease

Author(s): Michal Mielcarek, Mark Isalan
Published in: Clinical and Translational Medicine, Issue 4/1, 2015, ISSN 2001-1326
Publisher: Springer Verlag
DOI: 10.1186/s40169-015-0076-z

Deimmunization for gene therapy: host matching of synthetic zinc finger constructs enables long-term mutant Huntingtin repression in mice

Author(s): Carmen Agustín-Pavón, Michal Mielcarek, Mireia Garriga-Canut, Mark Isalan
Published in: Molecular Neurodegeneration, Issue 11/1, 2016, ISSN 1750-1326
Publisher: BioMed Central
DOI: 10.1186/s13024-016-0128-x

Huntington's disease is a multi-system disorder

Author(s): Michal Mielcarek
Published in: Rare Diseases, Issue 3/1, 2015, Page(s) e1058464, ISSN 2167-5511
Publisher: Taylor & Francis Online
DOI: 10.1080/21675511.2015.1058464

Intellectual Property Rights

Patent (1)

Peptides having zinc finger domains and uses thereof

Application/Publication number: EP 10187818
Date: 2010-10-15
Applicant(s): IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE